Sweden· SE-20140121000061
Xadago 50 mg Filmdragerad tablett
A medicinal product containing safinamide, registered in Sweden by Zambon SpA.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Safinamide
- Manufacturer
- Zambon SpA
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20140121000061
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Safinamide in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainSAFINAMIDA AUROVITAS 50 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGAurovitas Spain, S.A.U.
- CzechiaXADAGOZambon S.p.A., Bresso
- BelgiumSafinamide AB 50 mgAurobindo
- United StatesXadagoMDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.
- SwitzerlandXadago 50 mg, compresse rivestite con filmZambon Svizzera SA
- FinlandSafinamide VivantaVivanta Generics s.r.o.
- NetherlandsSafinamide Vivanta 50 mg filmomhulde tablettenVivanta Generics s.r.o.
- NorwayXadagoZambon SpA
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Belgium · Safinamide Ab, Safinamide Eg
- Cyprus · Orvago
- Germany · Safinamid Al, Safinamid Puren
- Denmark · Safinamid Vivanta
- Estonia · Safinamide Teva
- Spain · Safinamida Aurovitas, Safinamida Cinfa
- Finland · Safinamide Vivanta
- United Kingdom (Northern Ireland) · Safinamide Amarox, Safinamide Milpharm
- Greece · Orvago, Safinamide Win Medica
- Croatia · Safinamid Msn, Safinamide Msn
- Iceland · Xadago
- Italy · Safinamide Aurobindo, Safinamide Doc
- Liechtenstein · Xadago
- Lithuania · Safinamide Teva
- Luxembourg · Safinamide Eg
- Latvia · Safinamide Teva
- Malta · Safinamide Nio
- Netherlands · Safinamide Vivanta
- Norway · Safinamide Vivanta, Xadago
- Portugal · Safinamida Aurobindo, Safinamida Generis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aadf7cc4-36a0-48d4-bff4-29606b9849d8 GET /v1/drugs/aadf7cc4-36a0-48d4-bff4-29606b9849d8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20140121000061",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20140121000061",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/xadago"
}See everything about safinamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.